Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes

Analysis in primary cell cultures of human prostate carcinoma

Ida Silvestri, Susanna Cattarino, Annamaria Aglianò, Chiara Nicolazzo, Susanna Scarpa, Stefano Salciccia, Luigi Frati, Vincenzo Gentile, Alessandro Sciarra

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: To analyze the expression at basal level of inflammation-related cytokines and chemokines and the activation status of the NF-κB pathway, together with the proliferation and apoptosis indexes in two widely used in vitro tumor models, the androgen-dependent human Prostate Cancer (PC) cell line LNCaP and the androgen-independent PC3, and in primary cultures of human PC cells. To assess in these models and primary cultures, the effects of Serenoa repens (LSESr, Permixon®) on proliferation/apoptosis ratio, inflammation-related genes expression and NF-κB pathway activation. Methods. The expression of IL-6, CCL-5, CCL-2, COX-1, COX-2, iNOS inflammation-related genes has been evaluated at the mRNA level in two in vitro human PC models (LNCaP and PC3 cell lines) and in 40 independent human prostatic primary cultures obtained from PC patients undergoing radical prostatectomy. Tissue fragments were collected from both PC lesions and normal hyperplastic tissue counterparts for each case. All cultures were treated with two different amounts of Permixon® (44 and 88 μg/ml) for different time points (16, 24, 48 and 72 hours), depending on the cell type and the assay; the expression of inflammation-related genes, cell growth (proliferation/apoptosis ratio) and NF-κB activation has been analyzed in treated and untreated cells by means of semi-quantitative RNA-PCR, cell proliferation and immunofluorescence respectively. Results: We detected a significant reduction (p

Original languageEnglish
Article number11
JournalJournal of Inflammation (United Kingdom)
Volume10
Issue number1
DOIs
Publication statusPublished - 2013

Fingerprint

Serenoa
Primary Cell Culture
Cell culture
Prostate
Prostatic Neoplasms
Genes
Chemical activation
Apoptosis
Inflammation
Carcinoma
Androgens
Cells
Tissue
Cell proliferation
Cell growth
Chemokines
Gene expression
Cell Proliferation
Tumors
Interleukin-6

Keywords

  • Apoptosis
  • Caspase detection
  • Cell cultures
  • Inflammation
  • Proliferation
  • Prostate neoplasm

ASJC Scopus subject areas

  • Cell Biology
  • Clinical Biochemistry

Cite this

Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes : Analysis in primary cell cultures of human prostate carcinoma. / Silvestri, Ida; Cattarino, Susanna; Aglianò, Annamaria; Nicolazzo, Chiara; Scarpa, Susanna; Salciccia, Stefano; Frati, Luigi; Gentile, Vincenzo; Sciarra, Alessandro.

In: Journal of Inflammation (United Kingdom), Vol. 10, No. 1, 11, 2013.

Research output: Contribution to journalArticle

Silvestri, Ida ; Cattarino, Susanna ; Aglianò, Annamaria ; Nicolazzo, Chiara ; Scarpa, Susanna ; Salciccia, Stefano ; Frati, Luigi ; Gentile, Vincenzo ; Sciarra, Alessandro. / Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes : Analysis in primary cell cultures of human prostate carcinoma. In: Journal of Inflammation (United Kingdom). 2013 ; Vol. 10, No. 1.
@article{f7bf01b1f3f9489d9b08956b8ebd34f7,
title = "Effect of Serenoa repens (Permixon{\circledR}) on the expression of inflammation-related genes: Analysis in primary cell cultures of human prostate carcinoma",
abstract = "Background: To analyze the expression at basal level of inflammation-related cytokines and chemokines and the activation status of the NF-κB pathway, together with the proliferation and apoptosis indexes in two widely used in vitro tumor models, the androgen-dependent human Prostate Cancer (PC) cell line LNCaP and the androgen-independent PC3, and in primary cultures of human PC cells. To assess in these models and primary cultures, the effects of Serenoa repens (LSESr, Permixon{\circledR}) on proliferation/apoptosis ratio, inflammation-related genes expression and NF-κB pathway activation. Methods. The expression of IL-6, CCL-5, CCL-2, COX-1, COX-2, iNOS inflammation-related genes has been evaluated at the mRNA level in two in vitro human PC models (LNCaP and PC3 cell lines) and in 40 independent human prostatic primary cultures obtained from PC patients undergoing radical prostatectomy. Tissue fragments were collected from both PC lesions and normal hyperplastic tissue counterparts for each case. All cultures were treated with two different amounts of Permixon{\circledR} (44 and 88 μg/ml) for different time points (16, 24, 48 and 72 hours), depending on the cell type and the assay; the expression of inflammation-related genes, cell growth (proliferation/apoptosis ratio) and NF-κB activation has been analyzed in treated and untreated cells by means of semi-quantitative RNA-PCR, cell proliferation and immunofluorescence respectively. Results: We detected a significant reduction (p",
keywords = "Apoptosis, Caspase detection, Cell cultures, Inflammation, Proliferation, Prostate neoplasm",
author = "Ida Silvestri and Susanna Cattarino and Annamaria Aglian{\`o} and Chiara Nicolazzo and Susanna Scarpa and Stefano Salciccia and Luigi Frati and Vincenzo Gentile and Alessandro Sciarra",
year = "2013",
doi = "10.1186/1476-9255-10-11",
language = "English",
volume = "10",
journal = "Journal of inflammation",
issn = "1078-7852",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes

T2 - Analysis in primary cell cultures of human prostate carcinoma

AU - Silvestri, Ida

AU - Cattarino, Susanna

AU - Aglianò, Annamaria

AU - Nicolazzo, Chiara

AU - Scarpa, Susanna

AU - Salciccia, Stefano

AU - Frati, Luigi

AU - Gentile, Vincenzo

AU - Sciarra, Alessandro

PY - 2013

Y1 - 2013

N2 - Background: To analyze the expression at basal level of inflammation-related cytokines and chemokines and the activation status of the NF-κB pathway, together with the proliferation and apoptosis indexes in two widely used in vitro tumor models, the androgen-dependent human Prostate Cancer (PC) cell line LNCaP and the androgen-independent PC3, and in primary cultures of human PC cells. To assess in these models and primary cultures, the effects of Serenoa repens (LSESr, Permixon®) on proliferation/apoptosis ratio, inflammation-related genes expression and NF-κB pathway activation. Methods. The expression of IL-6, CCL-5, CCL-2, COX-1, COX-2, iNOS inflammation-related genes has been evaluated at the mRNA level in two in vitro human PC models (LNCaP and PC3 cell lines) and in 40 independent human prostatic primary cultures obtained from PC patients undergoing radical prostatectomy. Tissue fragments were collected from both PC lesions and normal hyperplastic tissue counterparts for each case. All cultures were treated with two different amounts of Permixon® (44 and 88 μg/ml) for different time points (16, 24, 48 and 72 hours), depending on the cell type and the assay; the expression of inflammation-related genes, cell growth (proliferation/apoptosis ratio) and NF-κB activation has been analyzed in treated and untreated cells by means of semi-quantitative RNA-PCR, cell proliferation and immunofluorescence respectively. Results: We detected a significant reduction (p

AB - Background: To analyze the expression at basal level of inflammation-related cytokines and chemokines and the activation status of the NF-κB pathway, together with the proliferation and apoptosis indexes in two widely used in vitro tumor models, the androgen-dependent human Prostate Cancer (PC) cell line LNCaP and the androgen-independent PC3, and in primary cultures of human PC cells. To assess in these models and primary cultures, the effects of Serenoa repens (LSESr, Permixon®) on proliferation/apoptosis ratio, inflammation-related genes expression and NF-κB pathway activation. Methods. The expression of IL-6, CCL-5, CCL-2, COX-1, COX-2, iNOS inflammation-related genes has been evaluated at the mRNA level in two in vitro human PC models (LNCaP and PC3 cell lines) and in 40 independent human prostatic primary cultures obtained from PC patients undergoing radical prostatectomy. Tissue fragments were collected from both PC lesions and normal hyperplastic tissue counterparts for each case. All cultures were treated with two different amounts of Permixon® (44 and 88 μg/ml) for different time points (16, 24, 48 and 72 hours), depending on the cell type and the assay; the expression of inflammation-related genes, cell growth (proliferation/apoptosis ratio) and NF-κB activation has been analyzed in treated and untreated cells by means of semi-quantitative RNA-PCR, cell proliferation and immunofluorescence respectively. Results: We detected a significant reduction (p

KW - Apoptosis

KW - Caspase detection

KW - Cell cultures

KW - Inflammation

KW - Proliferation

KW - Prostate neoplasm

UR - http://www.scopus.com/inward/record.url?scp=84874936396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874936396&partnerID=8YFLogxK

U2 - 10.1186/1476-9255-10-11

DO - 10.1186/1476-9255-10-11

M3 - Article

VL - 10

JO - Journal of inflammation

JF - Journal of inflammation

SN - 1078-7852

IS - 1

M1 - 11

ER -